Delivery Order SPE2DB24D2013-SPE2DB25FCHLR

Award Date 2/24/25
Potential Completion Date 2/25/25
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,954.55 firm fixed-price delivery order is for the supply of BRIVIACT 100 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of January 3, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award, valued at $2,553.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product. This is a Firm Fixed Price delivery order contract with an ultimate completion date of November 12, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds...
This federal contract award, valued at $1,859.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIVIACT 75 MG TABLET 60S, a pharmaceutical product, and has a completion date of February 26, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,379.13 Firm Fixed Price Delivery Order is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,786.07, is a delivery order for the supply of BRIVIACT 100 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price arrangement. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,086.40, is a Firm Fixed Price Delivery Order for the supply of BRIVIACT 100 MG TABLET 60S, a medication. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,789.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product, with a completion date of January 30, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $5,094.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIVIACT 50 MG TABLET 60S, a medical product. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $1,761.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIVIACT 25 MG TABLET 60S, with a completion date of December 10, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,227.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566716745 - BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of December 16, 2024 and is structured as a firm fixed-price delivery order. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp...
  • SPE2DB24D2013
    Indefinite Delivery Contract
  • SPE2DB24D2013-SPE2DB25FCHLR
    Delivery Order

This federal contract award, valued at $7,639.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, with a completion date of February 25, 2025. The contract is a Delivery Order under a Firm Fixed Price contract type. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/1/25, 3:26 AM